PALOMA-3研究分析：氟维司群联合Palbociclib显著提高内分泌治疗进展的晚期乳腺癌的无进展生存期

1文献来源Cristofanilli M,Turner NC,Bondarenko I,et al.Fulvestrant plus Palbociclib versus Fulvestrant plus placebo for treatment of hormone-receptorpositive,HER2-negative metastatic breast cancer that progressed on previous endocrine therapy（PALOMA-3）：Final analysis of the multicentre,double-blind,phase 3 randomised controlled trial[J].Lancet Oncol,2016,17（4）：425-439.